Effects of SGLT2 Inhibitor in Diabetic Patients With Coronary Artery Disease

NCT03398577 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

61

Enrollment

OTHER_GOV

Sponsor class

Conditions

Coronary Disease With Diabetes Mellitus

Interventions

DRUG: Dapagliflozin 10 MG [Farxiga]
DRUG: Placebo Oral Tablet

Sponsor

Sheba Medical Center